The coronavirus illness 2019 (COVID-19) pandemic, brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is threatening folks’s lives and impacting their well being. It’s nonetheless unclear whether or not folks engaged in bodily exercise are at an elevated danger of SARS-CoV-2 an infection and extreme types of COVID-19.
To be able to present knowledge to assist reply this query, we, subsequently, investigated the results of endurance coaching on the degrees of host proteins concerned in SARS-CoV-2 an infection in mice. Eight-week-old C57BL/6J mice have been subjected to treadmill operating (17-25 m/min, 60-90 min, 5 classes/week, eight weeks).
After the intervention, the degrees of angiotensin-converting enzyme 2 (ACE2; host receptor for SARS-CoV-2), transmembrane protease serine 2 (TMPRSS2; host protease priming fusion of SARS-CoV-2 to host cell membranes), FURIN (host protease that promotes binding of SARS-CoV-2 to host receptors), and Neuropilin-1 (host coreceptor for SARS-CoV-2) have been measured in 10 organs that SARS-CoV-2 can infect (larynx, trachea, lung, coronary heart, jejunum, ileum, colon, liver, kidney, and testis).
Six organs (coronary heart, lung, jejunum, liver, trachea, and ileum) confirmed modifications within the ranges of at the very least one of many proteins. Endurance coaching elevated ACE2 ranges in coronary heart (+66.4%), lung (+37.1%), jejunum (+24.7%) and liver (+27.4%), and FURIN in liver (+17.9%) tissue. In distinction, endurance coaching decreased Neuropilin-1 ranges in liver (-39.7%), trachea (-41.2%), and ileum (-39.7%), and TMPRSS2 in lung (-11.3%). Taken collectively, endurance coaching altered the degrees of host proteins concerned in SARS-CoV-2 cell entry in an organ-dependent method.

A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 An infection and Its Software in a Inhabitants-Based mostly Survey by Mail

Noninvasive salivary antibody immunoassays can allow low-cost epidemiological surveillance of infections. This research concerned creating and validating a multiplex suspension immunoassay on the Luminex platform to measure immunoglobulin G (IgG) responses to extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid and spike (S) proteins, and the spike protein’s S1 and S2 subunits and receptor binding area.
A number of variations of those recombinant proteins acquired from industrial and noncommercial sources have been evaluated. Assay growth and validation utilized saliva and serum samples from coronavirus illness 2019 (COVID-19) instances procured from industrial sources and damaging controls from a prepandemic survey.
Saliva was additionally collected in an illustration survey by mail involving grownup people in the US who have been recognized with SARS-CoV-2 an infection 15 to 80 days previous to pattern assortment. The survey had an 83% legitimate pattern return price (192 samples from 38 states).
Most COVID-19 instances (93%) reported mildly symptomatic or asymptomatic infections. The ultimate salivary assay primarily based on the best-performing spike and nucleocapsid proteins had a sensitivity of 87.1% (95% bootstrap confidence interval, 82.1 to 91.7%) and specificity of 98.5% (95.Zero to 100%) utilizing 227 and 285 saliva samples, respectively.
The identical assay had 95.9% (92.eight to 98.9%) sensitivity and 100% (98.Four to 100%) specificity in serum (174 and 285 serum samples, respectively). Salivary and serum antibody responses to spike and nucleocapsid proteins have been strongly correlated in 22 paired samples (r = 0.88 and r = 0.80, respectively). Antibody responses peaked at roughly 50 days postonset; higher sickness severity was related to stronger responses.
This research demonstrated {that a} salivary antibody assay can be utilized in large-scale inhabitants surveys by mail to raised characterize public well being impacts of COVID-19. IMPORTANCE Given the big impacts of the COVID-19 pandemic, creating instruments for inhabitants surveillance of an infection is of paramount significance.
This text describes the event of a multiplex immunoassay on a Luminex platform to measure salivary immunoglobulin G responses to the spike protein, its two subunits and receptor binding area, and the nucleocapsid protein of SARS-CoV-2. The assay validation utilized serum and saliva samples from prepandemic controls and up to date COVID-19 instances.
A survey by mail focusing on current COVID-19 instances throughout the US additionally demonstrated the utility of secure, at-home self-collection of saliva. By incorporating a number of SARS-CoV-2 proteins, this assay might differentiate responses to pure SARS-CoV-2 infections from responses to most vaccines.
Software of this noninvasive immunoassay in COVID-19 surveillance will help present estimates of cumulative incidence charges of symptomatic and asymptomatic infections in varied communities and subpopulations, temporal patterns of antibody responses, and danger components for an infection.

Roborovski hamster (Phodopus roborovskii) pressure SH101 as a systemic an infection mannequin of SARS-CoV-2

Extreme acute respiratory syndrome CoV-2 (SARS-CoV-2) is presently inflicting a worldwide menace with its unusually excessive transmission charges and fast evolution into various strains. In contrast to typical respiratory viruses, SARS-CoV-2 ceaselessly causes systemic an infection by breaking the boundaries of the respiratory methods.
The event of animal fashions recapitulating the medical manifestations of COVID-19 is of utmost significance not just for the event of vaccines and antivirals but additionally for understanding the pathogenesis. Nonetheless, there has not been developed an animal mannequin for systemic an infection of SARS-CoV-2 representing most features of the medical manifestations of COVID-19 with systemic signs.
Right here we report {that a} Roborovski hamster pressure SH101, a laboratory inbred hamster pressure of P. roborovskii, displayed most signs of systemic an infection upon SARS-CoV-2 an infection as within the case of the human counterpart, in contrast to present COVID-19 animal fashions.
Roborovski hamster pressure SH101 post-infection of SARS-CoV-2 represented most medical signs of COVID-19 resembling snuffling, labored respiratory, dyspnea, cough, hunched posture, progressive weight reduction, ruffled fur, and excessive fever following shaking chills.
Histological examinations additionally revealed preliminary right-predominated pneumonia in addition to slight organ damages within the mind and liver, manifesting systemic COVID-19 instances. Contemplating the advantage of a small animal in addition to its medical manifestations of SARS-CoV-2 an infection in human, this hamster mannequin appears to supply a perfect software to research COVID-19.

A mathematical mannequin for the dynamics of SARS-CoV-2 virus utilizing the Caputo-Fabrizio operator

The pandemic of SARS-CoV-2 virus stays a urgent problem with unpredictable traits which unfold worldwide via human interactions. The present research is specializing in the investigation and evaluation of a fractional-order epidemic mannequin that discusses the temporal dynamics of the SARS-CoV-2 virus in a group. It’s well-known that symptomatic and asymptomatic people have a significant impact on the dynamics of the SARS-CoV-2 virus subsequently, we divide the whole inhabitants into inclined, asymptomatic, symptomatic, and recovered teams of the inhabitants.
Additional, we assume that the vaccine confers everlasting immunity as a result of a number of vaccinations have commenced throughout the globe. The brand new fractional-order mannequin for the transmission dynamics of SARS-CoV-2 virus is formulated by way of the Caputo-Fabrizio fractional-order method with the upkeep of dimension in the course of the technique of fractionalization.
The speculation of mounted level will probably be used to point out that the proposed mannequin possesses a novel answer whereas the well-posedness (bounded-ness and positivity) of the fractional-order mannequin options are mentioned.

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-100ug
QP13422-100ug 100ug
EUR 218

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-1mg
QP13422-1mg 1mg
EUR 1061

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-500ug
QP13422-500ug 500ug
EUR 663

Recombinant SARS Associated Spike Mosaic S(N)
7-07093 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S(N)
7-07094 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S(N)
7-07095 1000µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07096 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07097 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07098 1000µg Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07099 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07100 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07101 1000µg Ask for price

SARS Associated Spike Mosaic S(M) Protein
20-abx260155
  • EUR 885.00
  • EUR 342.00
  • EUR 1372.00
  • 0.5 mg
  • 100 ug
  • 1 mg

SARS Associated Spike Mosaic S(N) Protein
20-abx260157
  • EUR 885.00
  • EUR 342.00
  • EUR 1372.00
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1422 100 ug
EUR 286

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1423 100 ug
EUR 286

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1424 100 ug
EUR 286

SARS Coronavirus Spike Mosaic Recombinant protein (Center)
39-122 0.1 mg
EUR 464
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

Recombinant SARS Spike Mosaic Protein S (N-Terminal)
VAng-Lsx0073-inquire inquire Ask for price
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli.

SARS Coronavirus Spike Mosaic Recombinant protein (C-terminus)
39-123 0.1 mg
EUR 464
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

SARS Coronavirus Spike Mosaic Recombinant protein (N-terminus)
39-124 0.1 mg
EUR 464
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

SARS-CoV-2 (COVID-19) Nucleocapsid Mosaic Recombinant protein
39-115 0.05 mg
EUR 464
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

SARS-CoV-2 (COVID-19) Spike E Mosaic Recombinant protein
39-114 0.05 mg
EUR 464
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573)
VAng-Lsx0056-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203)
VAng-Lsx0055-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190)
VAng-Lsx0057-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Sars/ Rat Sars ELISA Kit
ELI-41050r 96 Tests
EUR 886

Cytomegalo Virus Mosaic
PR27123 500 ug
EUR 833

SARS Antibody
1-CSB-PA04145A0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

SARS Antibody
1-CSB-PA020709GA01HU
  • EUR 597.00
  • EUR 333.00
  • 150ul
  • 50ul
Description: A polyclonal antibody against SARS. Recognizes SARS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

SARS siRNA
20-abx932473
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

SARS siRNA
20-abx932474
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

SARS siRNA
20-abx904776
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

SARS antibody
39139-100ul 100ul
EUR 252

SARS antibody
70R-20086 50 ul
EUR 435
Description: Rabbit polyclonal SARS antibody

SARS antibody
70R-1444 100 ug
EUR 377
Description: Rabbit polyclonal SARS antibody raised against the C terminal of SARS

SARS antibody
70R-1445 100 ug
EUR 377
Description: Rabbit polyclonal SARS antibody raised against the middle region of SARS

pENTR223-SARS
PVT12269 2 ug
EUR 391

SARS Antibody
DF15539 100ul
EUR 350

Turnip mosaic virus Polyprotein
1-CSB-EP2708TJM
  • EUR 611.00
  • EUR 309.00
  • EUR 1827.00
  • EUR 939.00
  • EUR 1218.00
  • EUR 397.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Turnip mosaic virus Polyprotein,partial expressed in E.coli

HTLV Mosaic protein [GST]
DAG1572 100 µg
EUR 645

EBV P18 Mosaic protein
DAG1582 100 µg
EUR 645

Rubella Virus E1 Mosaic
PR27125 500 ug
EUR 833

Recombinant HEV Mosaic Protein
VAng-Lsx0225-inquire inquire Ask for price
Description: HEV Mosaic Protein, recombinant protein from E. coli.

Recombinant Malaria Cs Mosaic
7-07090 100µg Ask for price

Recombinant Malaria Cs Mosaic
7-07091 500µg Ask for price

Recombinant Malaria Cs Mosaic
7-07092 1000µg Ask for price

Recombinant Cytomegalo Virus Mosaic
7-07525 100µg Ask for price

Recombinant Cytomegalo Virus Mosaic
7-07526 500µg Ask for price

Recombinant Cytomegalo Virus Mosaic
7-07527 1000µg Ask for price

Recombinant HTLV-1 Mosaic
7-07771 100µg Ask for price

Recombinant HTLV-1 Mosaic
7-07772 500µg Ask for price

Recombinant HTLV-1 Mosaic
7-07773 1000µg Ask for price

HTLV-1 Mosaic Protein
20-abx260286
  • EUR 885.00
  • EUR 342.00
  • EUR 1609.00
  • 0.5 mg
  • 100 ug
  • 1 mg

Malaria Cs Mosaic Protein
20-abx260295
  • EUR 885.00
  • EUR 342.00
  • EUR 1609.00
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant SARS SARS Core Protein, Untagged, E.coli-100ug
QP10499-100ug 100ug
EUR 218

Recombinant SARS SARS Core Protein, Untagged, E.coli-1mg
QP10499-1mg 1mg
EUR 1061

Recombinant SARS SARS Core Protein, Untagged, E.coli-500ug
QP10499-500ug 500ug
EUR 663

Recombinant SARS SARS Core Protein, Untagged, E.coli-100ug
QP13416-100ug 100ug
EUR 218

Recombinant SARS SARS Core Protein, Untagged, E.coli-1mg
QP13416-1mg 1mg
EUR 1061

Recombinant SARS SARS Core Protein, Untagged, E.coli-500ug
QP13416-500ug 500ug
EUR 663

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-100ug
QP13417-100ug 100ug
EUR 218

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-1mg
QP13417-1mg 1mg
EUR 1061

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-500ug
QP13417-500ug 500ug
EUR 663

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-100ug
QP13418-100ug 100ug
EUR 218

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-1mg
QP13418-1mg 1mg
EUR 1061

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-500ug
QP13418-500ug 500ug
EUR 663

Recombinant SARS SARS MERS Protein, His, E.coli-100ug
QP13419-100ug 100ug
EUR 218

Recombinant SARS SARS MERS Protein, His, E.coli-1mg
QP13419-1mg 1mg
EUR 1261

Recombinant SARS SARS MERS Protein, His, E.coli-500ug
QP13419-500ug 500ug
EUR 663

Recombinant SARS SARS-CoV Protein, His, E.coli-1mg
QP13423-1mg 1mg
EUR 3954

Recombinant SARS SARS-CoV Protein, His, E.coli-20ug
QP13423-20ug 20ug
EUR 201

Recombinant SARS SARS-CoV Protein, His, E.coli-5ug
QP13423-5ug 5ug
EUR 155

SARS cloning plasmid
CSB-CL020709HU1-10ug 10ug
EUR 376
Description: A cloning plasmid for the SARS gene.

SARS cloning plasmid
CSB-CL020709HU2-10ug 10ug
EUR 376
Description: A cloning plasmid for the SARS gene.

SARS S1 [His]
DAG1861 500 ug
EUR 2529

SARS S2 [His]
DAG1862 500 ug
EUR 2529

Anti-SARS antibody
STJ28816 100 µl
EUR 277
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown.

Anti-SARS antibody
STJ115313 100 µl
EUR 277
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown.

SARS Spike Antibody
24216-100ul 100ul
EUR 390

SARS Spike Antibody
24217-100ul 100ul
EUR 390

SARS Spike Antibody
24218-100ul 100ul
EUR 390

SARS Spike Antibody
24219-100ul 100ul
EUR 390

SARS Spike Antibody
24318-100ul 100ul
EUR 390

SARS Matrix Antibody
24319-100ul 100ul
EUR 390

SARS Matrix Antibody
24320-100ul 100ul
EUR 390

SARS Envelope Antibody
24321-100ul 100ul
EUR 390

SARS Envelope Antibody
24322-100ul 100ul
EUR 390

SARS Rabbit pAb
A13350-100ul 100 ul
EUR 308

SARS Rabbit pAb
A13350-200ul 200 ul
EUR 459

SARS Rabbit pAb
A13350-20ul 20 ul
EUR 183

SARS Rabbit pAb
A13350-50ul 50 ul
EUR 223

SARS Spike Antibody
20-abx137184
  • EUR 1052.00
  • EUR 1539.00
  • EUR 1720.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Nucleocapsid Antibody
20-abx137185
  • EUR 1052.00
  • EUR 1539.00
  • EUR 1970.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Spike Antibody
20-abx137200
  • EUR 1177.00
  • EUR 1887.00
  • EUR 2221.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Nucleocapsid Antibody
20-abx137201
  • EUR 1177.00
  • EUR 1887.00
  • EUR 2221.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS-E2 Antibody
abx016055-100ul 100 ul
EUR 411

SARS-M Antibody
abx016056-100ul 100 ul
EUR 411

SARS Polyclonal Antibody
A53977 100 µg
EUR 570.55
Description: The best epigenetics products

SARS Rabbit pAb
A6733-100ul 100 ul
EUR 308

SARS Rabbit pAb
A6733-200ul 200 ul
EUR 459

SARS Rabbit pAb
A6733-20ul 20 ul
EUR 183

SARS Rabbit pAb
A6733-50ul 50 ul
EUR 223

SARS Conjugated Antibody
C39139 100ul
EUR 397

anti- SARS antibody
FNab07609 100µg
EUR 548.75
Description: Antibody raised against SARS

SARS Protease Substrate
H-5982.0500 0.5mg
EUR 297
Description: Sum Formula: C66H119N21O22S; CAS# [587886-51-9] net

SARS Protease Substrate
H-5982.1000 1.0mg
EUR 515
Description: Sum Formula: C66H119N21O22S; CAS# [587886-51-9] net

SARS Spike Peptide
3219P 0.05 mg
EUR 164.75
Description: (NT) SARS Spike peptide

SARS Spike Peptide
3525P 0.05 mg
EUR 164.75
Description: (CT) SARS Spike peptide

SARS Matrix Peptide
3527P 0.05 mg
EUR 164.75
Description: (NT) SARS Matrix peptide

SARS Matrix Peptide
3529P 0.05 mg
EUR 164.75
Description: (CT) SARS Matrix peptide

SARS Envelope Peptide
3531P 0.05 mg
EUR 164.75
Description: (NT) SARS Envelope peptide

SARS Envelope Peptide
3533P 0.05 mg
EUR 164.75
Description: (CT) SARS Envelope peptide

SARS Blocking Peptide
33R-7048 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARS antibody, catalog no. 70R-1444

SARS Blocking Peptide
33R-8713 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARS antibody, catalog no. 70R-1445

SARS E2 antibody
10R-1976 100 ul
EUR 241
Description: Mouse monoclonal SARS E2 antibody

SARS M antibody
10R-1977 100 ul
EUR 241
Description: Mouse monoclonal SARS M antibody

SARS Coronavirus antibody
10C-CR9003M1 100 ug
EUR 499
Description: Mouse monoclonal SARS Coronavirus antibody

SARS Nucleocapsid antibody
10R-10470 100 ug
EUR 435
Description: Mouse monoclonal SARS Nucleocapsid antibody

SARS Nucleocapsid antibody
10R-10471 100 ug
EUR 435
Description: Mouse monoclonal SARS Nucleocapsid antibody

Anti-SARS antibody
PAab07609 100 ug
EUR 386

Anti-SARS (1H4)
YF-MA10816 100 ug
EUR 363
Description: Mouse monoclonal to SARS

Cucumber mosaic virus Helicase (ORF1a)
1-CSB-CF2240CMV
  • EUR 965.00
  • EUR 665.00
  • EUR 715.00
  • 1MG
  • 200ug
  • 500ug
Description: Recombinant Cucumber mosaic virus Helicase(ORF1a) expressed in in vitro E.coli expression system

HTLV Glycoprotein 46 Mosaic protein
DAG1571 100 µg
EUR 645

EBV Mosaic EBNA1 protein [GST]
DAG1577 100 µg
EUR 645

Arthrobacter globiformis Mosaic Protein [His]
DAG1731 100 ug
EUR 915

HCV NS4 mosaic recombinant antigen
00155-V-01mg 0,1 mg
EUR 267.5
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5.

HCV NS4 mosaic recombinant antigen
00155-V-1000ug 1000 ug
EUR 1282.5
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5.

Recombinant HEV Mosaic-S Protein
VAng-Lsx0226-inquire inquire Ask for price
Description: HEV Mosaic-S Protein, recombinant protein from E. coli.

Rubella Virus E1 Mosaic Protein
abx060646-1mg 1 mg
EUR 1845

Rubella Virus E1 Mosaic Protein
abx060647-1mg 1 mg
EUR 1497

Recombinant Treponema pallidum p41 Mosaic
7-07570 100µg Ask for price

Recombinant Treponema pallidum p41 Mosaic
7-07571 500µg Ask for price

Recombinant Treponema pallidum p41 Mosaic
7-07572 1000µg Ask for price

Recombinant Rubella Virus E1 Mosaic
7-07858 100µg Ask for price

Recombinant Rubella Virus E1 Mosaic
7-07859 500µg Ask for price

Recombinant Rubella Virus E1 Mosaic
7-07860 1000µg Ask for price

Treponema pallidum p41 Mosaic Protein
20-abx260173
  • EUR 885.00
  • EUR 342.00
  • EUR 1372.00
  • 0.5 mg
  • 100 ug
  • 1 mg

Rubella Virus E1 Mosaic Protein
20-abx260310
  • EUR 885.00
  • EUR 342.00
  • EUR 1609.00
  • 0.5 mg
  • 100 ug
  • 1 mg

Cucumber Mosaic Virus ELISA Kit
abx157282-96tests 96 tests
EUR 668

Recombinant MeV Hemagglutinin Mosaic Protein
VAng-Lsx0386-inquire inquire Ask for price
Description: Recombinant MeV HA protein containing the large hemagglutinin immunodominant regions 1-30, 115-150 and 379-410 amino acids was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant MeV Fusion Mosaic Protein
VAng-Lsx0387-inquire inquire Ask for price
Description: MeV Fusion Mosaic protein, recombinant protein from E. coli.

Recombinant EBV P18 Mosaic Protein
VAng-Lsx0115-inquire inquire Ask for price
Description: EBV P18 Mosaic protein, recombinant protein from E. coli.

Recombinant RuV E1 Mosaic Protein
VAng-Lsx0488-100g 100 µg
EUR 963
Description: RuV E1 Mosaic, recombinant protein from E. coli.

Recombinant RuV E1 Mosaic Protein
VAng-Lsx0488-1mg 1 mg
EUR 2156
Description: RuV E1 Mosaic, recombinant protein from E. coli.

Recombinant RuV E1 Mosaic Protein
VAng-Lsx0488-500g 500 µg
EUR 1577
Description: RuV E1 Mosaic, recombinant protein from E. coli.

Recombinant HTLV Mosaic Protein [GST]
VAng-Lsx0304-inquire inquire Ask for price
Description: Recombinant HTLV protein fused with GST at N-terminus was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant HTLV-1 Mosaic Protein
VAng-Lsx0310-inquire inquire Ask for price
Description: HTLV type 1 Mosaic Protein, recombinant protein from E. coli.

Recombinant (E.Coli) Circumsporozoite (CSP) mosaic protein (107-129, 334-351 aa) (P.falciparum) mosaic protein
CSPF16-R 50 ug
EUR 347

SARS Antibody, HRP conjugated
1-CSB-PA04145B0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

SARS Antibody, FITC conjugated
1-CSB-PA04145C0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

SARS Antibody, Biotin conjugated
1-CSB-PA04145D0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Mouse SARS shRNA Plasmid
20-abx972567
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

Polyclonal SARS Matrix Antibody
APR11178G 0.1 mg
EUR 659
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SARS Matrix . This antibody is tested and proven to work in the following applications:

Polyclonal SARS Matrix Antibody
APG02976G 0.1 mg
EUR 659
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SARS Matrix . This antibody is tested and proven to work in the following applications:

Rat SARS shRNA Plasmid
20-abx988123
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

Human SARS shRNA Plasmid
20-abx954245
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

SARS CoV E Protein
abx060650-1mg 1 mg
EUR 1692

SARS CoV Nucleocapsid Protein
abx060652-1mg 1 mg
EUR 1873

SARS-CoV Nucleocapsid Protein
abx060653-1mg 1 mg
EUR 1692

SARS-CoV Nucleocapsid Protein
abx060654-1mg 1 mg
EUR 1692

SARS-CoV Spike Protein
abx060655-1mg 1 mg
EUR 1692

SARS virus Sn Antibody
abx032683-400ul 400 ul
EUR 523

SARS virus Sn Antibody
abx032683-80l 80 µl
EUR 286

SARS virus Sm Antibody
abx032684-400ul 400 ul
EUR 523

SARS virus Sm Antibody
abx032684-80l 80 µl
EUR 286

ACE2 (SARS Receptor) Antibody
abx032686-400ul 400 ul
EUR 523

ACE2 (SARS Receptor) Antibody
abx032686-80l 80 µl
EUR 286

SARS N Protein Antibody
abx018255-100ug 100 ug
EUR 384

SARS N Protein Antibody
abx018256-100ug 100 ug
EUR 384

Recombinant SARS Matrix Protein
VAng-Lsx0059-inquire inquire Ask for price
Description: SARS Matrix, recombinant protein from E. coli.

Anti-SARS-E2 antibody
STJ98377 100 µl
EUR 234
Description: Mouse monoclonal to SARS-E2.

Anti-SARS-M antibody
STJ98378 100 µl
EUR 234
Description: Mouse monoclonal to SARS-M.

SARS ELISA KIT|Human
EF002719 96 Tests
EUR 689

anti-SARS-E2 (4A6C9)
LF-MA30016 100 ul
EUR 344
Description: Mouse Monoclonal to SARS-E2

anti-SARS-M (2H2C4)
LF-MA30017 100 ul
EUR 354
Description: Mouse Monoclonal to SARS-M

SARS protein (His tag)
80R-2099 50 ug
EUR 322
Description: Recombinant human SARS protein (His tag)

SARS-CoV Spike Antibody
3219-002mg 0.02 mg
EUR 171.82
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3219-01mg 0.1 mg
EUR 436.42
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-002mg 0.02 mg
EUR 171.82
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-01mg 0.1 mg
EUR 436.42
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-002mg 0.02 mg
EUR 171.82
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-01mg 0.1 mg
EUR 436.42
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3225-002mg 0.02 mg
EUR 171.82
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3225-01mg 0.1 mg
EUR 436.42
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Matrix Antibody
3527-002mg 0.02 mg
EUR 171.82
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody
3527-01mg 0.1 mg
EUR 436.42
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody
3529-002mg 0.02 mg
EUR 171.82
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody
3529-01mg 0.1 mg
EUR 436.42
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Envelope Antibody
3533-002mg 0.02 mg
EUR 171.82
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.

SARS-CoV Envelope Antibody
3533-01mg 0.1 mg
EUR 436.42
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.

SARS (IN1) Spike Peptide
3221P 0.05 mg
EUR 164.75
Description: (IN) SARS (IN1) Spike peptide

SARS (IN2) Spike Peptide
3223P 0.05 mg
EUR 164.75
Description: (IN) SARS (IN2) Spike peptide

SARS (IN3) Spike Peptide
3225P 0.05 mg
EUR 164.75
Description: (IN) SARS (IN3) Spike peptide

SARS Nucleocapsid Recombinant Protein
10-213 0.1 mL
EUR 626.75
Description: The nucleocapsid (N) protein of SARS-coronavirus (SARS-CoV) is the key protein for the formation of the helical nucleocapsid during virion assembly. The nucleocapsid (N) protein of SARS-CoV enters the host cell together with the viral RNA and interferes with several cellular processes. Some of these processes involve interactions between SARS-CoV N protein and host- cell proteins. It has also been demonstrated that the SARS-CoV N protein can bind to DNA in vitro. These interactions might have a role in the pathology of SARS. The N protein may be of potential value in vaccine development for specific prophylaxis and treatment against SARS.

SARS Protein Detection Set
PSI-1810 1 Set
EUR 737
Description: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral S (Spike) protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. The M protein (Membrane protein, Matrix protein) is another major structural viral protein. It is an integral membrane protein involved in the budding of the viral particles and interacts with S protein and the nucleocapsid protein. The SARS E protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. ACE2, the SARS receptor, normally plays a central role in vascular, renal, and myocardial physiology. In contrast to its homolog ACE, ACE2 expression is restricted to heart, kidney, and testis.;;For images please see PDF data sheet

SARS Recombinant Protein (Human)
RP027604 100 ug Ask for price
The regular states of the mannequin are analyzed and the sensitivity evaluation of the fundamental reproductive quantity is explored. Furthermore to parameterize the mannequin an actual knowledge of SARS-CoV-2 virus reported within the Sultanate of Oman from January 1st, 2021 to Could 23rd, 2021 are used. We then carry out the massive scale numerical findings to point out the validity of the analytical work.

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here